Schedule 13G ownership disclosure

REVIVA PHARMACEUTCLS HLDGS I

Common Stock, par value $0.0001 per share · CUSIP: 76152G100

Event date: 2024-12-31

Filing-level shares
1,314,915.00
Percent of class
2.82%
  • Schonfeld Strategic Advisors LLC

    Shares: 1,314,915.00 · Class: 2.82%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-25-000195
Form type
SCHEDULE 13G/A
Filer
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK
CIK 1742927
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub